1.
Gottlieb A, Thaci D, Leonardi C, Poulin Y, Kavanagh S, Boehnlein M, Reich K. Nail Outcome Improvements with Certolizumab Pegol in Moderate to Severe Plaque Psoriasis: Results from Phase 3 Trials. J of Skin [Internet]. 2019 Nov. 9 [cited 2024 Jul. 3];3:S38. Available from: https://jofskin.org/33014/index.php/skin/article/view/765